This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Alunbrig — Description, Dosage, Side Effects | PillsCard
Rx
Alunbrig
30 mg, Tabletki powlekane
INN: Brigatinibum
Data updated: 2026-04-13
Available in:
🇨🇿🇬🇧🇫🇷🇵🇱🇸🇰
Form
Tabletki powlekane
Dosage
30 mg
Route
doustna
Storage
Store at controlled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) (see USP).
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Takeda Pharma A/S (Austria)
Composition
Brigatinibum 30 mg
ATC Code
L01ED04
Source
URPL
11 DESCRIPTION Brigatinib is a kinase inhibitor. The chemical name for brigatinib is 5-chloro-N 4 -[2-(dimethylphosphoryl)phenyl]-N 2 -{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine. The molecular formula is C 29 H 39 ClN 7 O 2 P which corresponds to a formula weight of 584.10 g/mol. Brigatinib has no chiral centers. The chemical structure is shown below: Brigatinib is an off-white to beige/tan solid. The pK a s were determined to be: 1.73 ± 0.02 (base), 3.65 ± 0.01 (base), 4.72 ± 0.01 (base), and 8.04 ± 0.01 (base). ALUNBRIG is supplied for oral use as film-coated tablets containing 180 mg, 90 mg or 30 mg of brigatinib and the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, sodium starch glycolate (Type A), magnesium stearate, and hydrophobic colloidal silica. The tablet coating consists of talc, polyethylene glycol, polyvinyl alcohol, and titanium dioxide. Chemical Structure
⚠️ Warnings
Patients should be advised to keep the desiccant canister in the bottle and not to swallow it.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements